Most trusted source for Tendering Opportunities and Business Intelligence since 2002
Country - Czech Republic
Summary - Medicinal Products Containing Nivolumab And Relatlimab, Cisplatins, Talazopariba, Ivosideniba, Hydroxycarbamide, Aflibercept, Tebentafusp
Deadline - Sep 29, 2025
GT reference number - 116693665
Product classification - Antineoplastic agents
Address - Czech Republic
Contact details - 565656565
Tender notice no. - 76454545
GT Ref Id - 116693665
Document Type - Tender Notices
Description - Description: The subject of the public contract is continuous supplies of medicinal products containing Nivolumab and Relatlimab, cisplatins, talazopariba, ivosidenib, hydroxycarbamide, Aflibercept, tebentafusp for 4 years according to the current ne eds of the contracting authority.local title:: Léčivé přípravky s obsahem nivolumabu a relatlimabu, cisplatiny, talazoparibu, ivosidenibu, hydroxykarbamidu, afliberceptu, tebentafuspuContract Duration: : 48 DAYContract Type: : Supplylocal description: : Předmětem veřejné zakázky jsou průběžné dodávky léčivých přípravků s obsahem nivolumabu a relatlimabu, cisplatiny, talazoparibu, ivosidenibu, hydroxykarbamidu, afliberceptu, t
Gt Ref Id - 116693665
Deadline - Sep 29, 2025
Similar Tenders :
Why Us
3,00,000 +
Users
190 +
Countries Covered
5,00,000 +
Agencies Tracked
50,000 +
Notices Daily
90 Million +
Database